Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 148 clinical trials for: 1000 miles

Recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
  • Recruiting
NCT06966453
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
  • Recruiting
NCT06758401
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  • Recruiting
NCT06807268
Sex: All
Age: 6 - 11
Locations: 21
View study
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  • Recruiting
NCT07028853
Sex: Male
Age: 18+
Locations: 38
View study
Recruiting
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
  • Recruiting
NCT05317416
Sex: All
Age: 18+
Locations: 223
View study
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
  • Recruiting
NCT06679140
Sex: All
Age: 12+
Locations: 186
View study
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  • Recruiting
NCT04649242
Sex: All
Age: 6 - 17
Locations: 242
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 244
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
  • Recruiting
NCT06616194
Sex: All
Age: 12 - 17
Locations: 88
View study
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  • Recruiting
NCT05156398
Sex: All
Age: 6 - 17
Locations: 94
View study
...